Literature DB >> 10494007

Migraine-associated symptoms: clinical significance and management.

W L Becker1.   

Abstract

Nausea is common in patients with migraine. A number of antiemetic drugs can be useful in migraine treatment, and those with a prokinetic action (metoclopramide and domperidone) may also improve gastrointestinal absorption of analgesics and triptans during a migraine attack. In addition to providing headache relief, the triptans are very effective in relieving migraine-associated nausea. For migraine patients with nausea and/or vomiting severe enough to interfere with the use of oral medications, alternative drug delivery methods can be used. These include the injectable, intranasal and rectal suppository routes, and specialized oral medications such as sublingual tablets and oral wafers that dissolve in the mouth. Fortunately, effective medications that use some of these alternative delivery routes have become more available over the past several years.

Entities:  

Mesh:

Year:  1999        PMID: 10494007

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN: 1198-581X


  4 in total

Review 1.  Dietary considerations in migraine management: does a consistent diet improve migraine?

Authors:  Alan G Finkel; Juanita A Yerry; J Douglas Mann
Journal:  Curr Pain Headache Rep       Date:  2013-11

Review 2.  Newer formulations of the triptans: advances in migraine management.

Authors:  Jonathan Paul Gladstone; Marek Gawel
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Formulation development and evaluation of zolmitriptan oral soluble films using 22 factorial designs.

Authors:  Poluri Koteswari; G Puja Sravanthi; M Mounika; S K Mohammed Rafi; K Nirosha
Journal:  Int J Pharm Investig       Date:  2016 Oct-Dec

4.  Italian guidelines for primary headaches: 2012 revised version.

Authors:  Paola Sarchielli; Franco Granella; Maria Pia Prudenzano; Luigi Alberto Pini; Vincenzo Guidetti; Giorgio Bono; Lorenzo Pinessi; Massimo Alessandri; Fabio Antonaci; Marcello Fanciullacci; Anna Ferrari; Mario Guazzelli; Giuseppe Nappi; Grazia Sances; Giorgio Sandrini; Lidia Savi; Cristina Tassorelli; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2012-05       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.